Table 1.
Demographics and baseline characteristics of patients infected with SARS-CoV-2.
| Baseline variables | All patients (N = 40) | Mild patients (N = 27) | Severe patients (N = 13) | |
|---|---|---|---|---|
| Characteristics | ||||
| Age (year) | 48·7 ± 13·9 | 43·2 ± 12·3 | 59·7 ± 10·1 | |
| Gender (%) | ||||
| Men | 15 (37·5) | 8 (29·6) | 7 (53·8) | |
| Women | 25 (62·5) | 19 (70·4) | 6 (46·2) | |
| Huanan seafood market exposure (%) | 3 (7·5) | 1 (3·7) | 2 (5·4) | |
| Current smoking | 5 (12·5) | 3 (11·1) | 2 (15·4) | |
| Underlying diseases (%) | 14 (35·0) | 7 (25·9) | 7 (53·8) | |
| Diabetes | 6 (15·0) | 2 (7·4) | 4 (30·8) | |
| Hypertension | 6 (15·0) | 1 (3·7) | 5 (38·5) | |
| Pituitary adenoma | 2 (5·0) | 1 (3·7) | 1 (7·7) | |
| Thyroid disease | 2 (5·0) | 2 (7·4) | 0 | |
| Malignancy | 2 (5·0) | 2 (7·4) | 0 | |
| Co-infection (%) | 5 (12·5) | 0 | 5 (38·5) | |
| Fungi | 4 (10·0) | 0 | 4 (30·8) | |
| Bacteria | 1 (2·5) | 0 | 1 (7·7) | |
| Signs and symptoms | ||||
| Fever | 36 (90·0) | 23 (85·2) | 13 (100) | |
| Highest temperature, °C | ||||
| <37.3 | 4 (10·0) | 4 (14·8) | 0 | |
| 37.3–38.0 | 10 (25·0) | 8 (29·6) | 2 (15·4) | |
| 38.1–39.0 | 17 (42·5) | 9 (33·3) | 8 (61·5) | |
| >39.0 | 9 (22·5) | 6 (22·2) | 3 (23·1) | |
| Chill | 10 (25·0) | 5 (18·5) | 5 (38·5) | |
| Shivering | 5 (12·5) | 2 (7·4) | 3 (23·1) | |
| Fatigue | 22 (55·0) | 14 (51·9) | 8 (61·5) | |
| Cough | 33 (82·5) | 22 (81·5) | 11 (84·6) | |
| Sputum production | 21 (52·5) | 11 (40·7) | 10 (76·9) | |
| Pharyngalgia | 5 (12·5) | 4 (14·8) | 1 (7·7) | |
| Dizziness | 7 (17·5) | 4 (14·8) | 3 (23·1) | |
| Headache | 8 (20·0) | 6 (22·2) | 2 (15·4) | |
| Rhinorrhea | 1 (2·5) | 1 (3·7) | 0 | |
| Chest tightness | 12 (30·0) | 7 (25·9) | 5 (38·5) | |
| Chest pain | 1 (2·5) | 1 (3·7) | 0 | |
| shortness of breath | 5 (12·5) | 5 (18·5) | 0 | |
| Dyspnea | 1 (2·5) | 1 (3·7) | 0 | |
| Myalgia | 15 (37·5) | 7 (25·9) | 8 (61·5) | |
| abdominal pain | 1 (2·5) | 1 (3·7) | 0 | |
| Diarrhea | 3 (7·5) | 1 (3·7) | 2 (15·4) | |
| Nausea | 3 (7·5) | 0 | 3 (23·1) | |
| Vomiting | 1 (2·5) | 0 | 1 (7·7) | |
| Hypoleucocytosis | 10 (25·0) | 8 (29·6) | 2 (15·4) | |
| Lymphopenia | 21 (52·5) | 11 (40·7) | 10 (76·9) | |
| Thrombocytopenia | 5 (12·5) | 3 (11·1) | 2 (15·4) | |
| Duration of hospitalization (day) | 12·6 ± 6·7 | 12·9 ± 7·1 | 11·8 ± 5·9 | |
| ARDS | 3 (7·5) | 0 | 3 (23·1) | |
| prognosis | ||||
| Hospitalization | 4 (10) | 1 (3·7) | 3 (23·1) | |
| Discharge | 33 (82·5) | 26 (96·3) | 7 (53·8) | |
| Death | 3 (7·5) | 0 | 3 (23·1) | |